Insmed Stock Price. Everything You Need To Know About The Insmed Stock!
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. The company is headquartered in Bridgewater, New Jersey and currently employs 736 full-time employees. The company is engaged in providing ARIKAYCE (amikacin liposome inhalation suspension) product, which is used for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its clinical-stage pipeline includes brensocatib and treprostinil palmitil inhalation powder (TPIP). Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1, which is developed for the treatment of patients with bronchiectasis, cystic fibrosis (CF) and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRS) and hidradenitis suppurativa (HS). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil which offers a differentiated product profile for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Insmed Stock Price. Everything You Need To Know About The Insmed Stock! performance
- Employees 736
- Company HQ Bridgewater
- Website https://insmed.com/
- INSM Asset Type Common Stock
- INSM Market Capitalization 3.8B
- Earnings Per Share -5.34
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further than Insmed, a promising stock with great potential. Insmed is a biopharmaceutical company focused on the development and commercialization of innovative therapies for patients with serious and rare diseases. With its strong pipeline of drugs and a track record of success, Insmed presents a great investment opportunity. But the question is, how can you invest in Insmed from Malaysia, Thailand, Indonesia, or Vietnam? Thankfully, with Zorion, it has become easier than ever. Zorion is an investment platform that allows retail investors from these countries to invest in real US stocks and pre-IPO companies. With Zorion’s user-friendly interface and investment insights, you can make informed decisions about your investment in Insmed. Furthermore, Zorion provides resources and educational materials to help you expand your investment knowledge. Whether you are a beginner or an experienced investor, you can access these materials to enhance your understanding of the stock market and make smarter investment choices. So, don’t miss out on the opportunity to invest in Insmed. Join Zorion today and start your journey towards financial success.
